This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Lipids and Lipid Disorders  • Genetics, Other  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Barzilai and colleagues¹ reported that families with exceptional longevity have significantly larger high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes, which are associated with increased homozygosity for the codon 405 isoleucine to valine (I405V) variant in the cholesteryl ester transfer protein (CETP) gene. These results, however, are at odds with previous studies. For instance, this genotype has been associated with increased risk of coronary artery disease (CAD) in the Copenhagen City Heart study.² Studies have also found that genetically determined deficiency of CETP activity may contribute to increased levels of possibly dysfunctional HDL cholesterol, which may actually increase risk of ischemic heart disease.² Based on 1749 consecutive patients with acute myocardial infarction, we have reported that this genotype is correlated with the extent of CAD on angiography.³ Finally, homozygosity for this allele was not found to be independently associated with CAD in a . . . [Full Text of this Article]

George K. Andrikopoulos, MD, FESC
geomabuz@otenet.gr
First Cardiac Department
Evangelismos Hospital

Dimitri J. Richter, MD
Second Cardiac Department
Euroclinic Hospital
Athens, Greece

RELATED ARTICLES

Genetic Factors in Exceptional Longevity—Reply
Nir Barzilai, Gil Atzmon, Clyde Schechter, Richard Lipton, and Alan R. Shuldiner
JAMA. 2004;291(8):942-943.
EXTRACT | FULL TEXT  

Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity
Nir Barzilai, Gil Atzmon, Clyde Schechter, Ernst J. Schaefer, Adrienne L. Cupples, Richard Lipton, Suzanne Cheng, and Alan R. Shuldiner
JAMA. 2003;290(15):2030-2040.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy
Rouse et al.
NEJM 2008;359:895-905.
ABSTRACT | FULL TEXT